Hong_2026_J.Microbiol.Biotechnol_36_e2510052

Reference

Title : Anti-Acne Potential of Quercus salicina Extract: Inhibition of Cutibacterium acnes Growth and Virulence - Hong_2026_J.Microbiol.Biotechnol_36_e2510052
Author(s) : Hong S , Park S , Park M , Park JM , Hwang DY , Lee H , Park J
Ref : J Microbiol Biotechnol , 36 :e2510052 , 2026
Abstract :

Acne vulgaris is a prevalent inflammatory skin disorder mediated by Cutibacterium acnes, a key etiological factor. In this study, the anti-acne properties of the ethyl acetate fraction of Quercus salicina Blume (QsB-EE) against C. acnes were investigated. The QsB-EE fraction was separated into subfractions (E1-E6) using preparative HPLC. Antimicrobial and anti-virulence activities were evaluated via bacterial growth, biofilm, and lipase activity assays. Virulence gene expression was assessed using qRT-PCR, and bioactive compounds were identified by LC-MS/MS. The QsB-EE demonstrated significant antimicrobial (MIC 125 microg/ml) and strong anti-virulence effects. The E1 fraction was the most potent, exhibiting the lowest MIC (16 microg/ml), highest biofilm inhibition (86.19% at 1,000 microg/ml), and highest lipase inhibition (93.72% at 10 microg/ml). In addition, mechanistic studies confirmed that E1 significantly downregulated the expression of key virulence genes: ppa0149 (biofilm), gehA (lipase), and hyl (hyaluronidase). LC-MS/MS identified (+)-catechin as the major compound in E1, alongside kaempferol and quercetin in E5. Although further in vivo studies are warranted to evaluate the therapeutic efficacy, our findings suggest that QsB-EE possesses promising anti-acne potential by targeting C. acnes virulence factors through the active compounds concentrated in the E1 fraction.

PubMedSearch : Hong_2026_J.Microbiol.Biotechnol_36_e2510052
PubMedID: 41539852

Related information

Citations formats

Hong S, Park S, Park M, Park JM, Hwang DY, Lee H, Park J (2026)
Anti-Acne Potential of Quercus salicina Extract: Inhibition of Cutibacterium acnes Growth and Virulence
J Microbiol Biotechnol 36 :e2510052

Hong S, Park S, Park M, Park JM, Hwang DY, Lee H, Park J (2026)
J Microbiol Biotechnol 36 :e2510052